Catheter-related-central venous thrombosis (CR-CVT) related to the subcutaneously implanted, Dacron-cuffed, central venous silastic catheter (Hickman/Broviac [HC/BC]) ... has been examined less extensively than the more common complication of catheter-related sepsis. In addition, oncologic patients have been less frequently evaluated than nutrition patients for CR-CVT. This study examines a large collection of CR-CVT related to the placement and use of HC/BC for long-term central venous access in an oncologic population.... the incidence of clinical CR-CVT related to placement and use of HC/BC is acceptably low (3.7%) in an oncologic population. Based upon this study, the occurrence cannot be predicted. Neither in this retrospective study nor in the literature does any specific treatment demonstrate clear superiority. Catheter function can be maintained until completion of the treatment for CR-CVT and subsequent catheter placement can be safely performed. Long-term sequelae can be minimized when CR-CVT is properly managed. Placement and use of HC/BC in oncology patients continues to be an acceptably safe method of long-term venous access.

Abstracted by permission from Journal of Parenteral and Enteral Nutrition.